Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
DNP – Die Neurologie & Psychiatrie
Erschienen in: DNP - Der Neurologe & Psychiater 6/2013

11.06.2013 | Fortbildung

Im Grenzgebiet zwischen Bewegungsstörungen und Epilepsien

Paroxysmale Dyskinesien

verfasst von: Dr. med. Adam Strzelczyk, Philipp S. Reif, Katrin Bürk, Wolfgang H. Oertel, Karl Martin Klein

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Zusammenfassung

Paroxysmale Dyskinesien sind seltene Erkrankungen, denen das anfallsartige Auftreten motorischer Symptome gemeinsam ist. In den letzten Jahren wurden die genetischen Ursachen für drei Formen der paroxysmalen Dyskinesien identifiziert. In der Folge musste das phänotypische Spektrum bei diesen Genotypen um verschiedene Epilepsiesyndrome, Migräne und neurokognitive Veränderungen erweitert werden. Dies ist von hoher diagnostischer und therapeutischer Relevanz, da bei bestimmten Mutationen hervorragende therapeutische Möglichkeiten zur Verfügung stehen.

Literatur
  1. Guerrini, R., Epilepsy and movement disorders. 2002, Cambridge; New York: Cambridge University Press. xxvii, 557 p.
  2. Kaplan, P.W. and R.S. Fisher, Imitators of epilepsy. 2nd ed. 2005, New York, NY: Demos. xv, 296 p.
  3. Crompton, D.E. and S.F. Berkovic, The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol, 2009. 8(4): p. 370–81PubMedView Article
  4. Goodenough, D.J., R.G. Fariello, B.L. Annis, et al., Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol, 1978. 35(12): p. 827–31.PubMedView Article
  5. Lance, J.W., Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol, 1977. 2(4): p. 285–93.PubMedView Article
  6. Mount, L.A. and S. Reback, Familial paroxysmal choreoathetosis. Arch Neurol Psychiatry, 1940. 44: p. 841–847.View Article
  7. Kertesz, A., Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology, 1967. 17(7): p. 680–90.PubMedView Article
  8. Demirkiran, M. and J. Jankovic, Paroxysmal dyskinesias: clinical features and classification. Ann Neurol, 1995. 38(4): p. 571–9.PubMedView Article
  9. Jankovic, J. and auM. Demirkiran}, Classification of paroxysmal dyskinesias and ataxias. Adv Neurol, 2002. 89: p. 387–400.PubMed
  10. Tinuper, P., A. Cerullo, F. Cirignotta, et al., Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures. Epilepsia, 1990. 31(5): p. 549–56.PubMedView Article
  11. Lugaresi, E., F. Cirignotta and P. Montagna, Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry, 1986. 49(4): p. 375–80.PubMedView Article
  12. Lugaresi, E. and F. Cirignotta, Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep, 1981. 4(2): p. 129–38.
  13. Kikuchi, T., M. Nomura, H. Tomita, et al., Paroxysmal kinesigenic choreoathetosis (PKC): confirmation of linkage to 16p11-q21, but unsuccessful detection of mutations among 157 genes at the PKC-critical region in seven PKC families. J Hum Genet, 2007. 52(4): p. 334–41.PubMedView Article
  14. Chen, W.J., Y. Lin, Z.Q. Xiong, et al., Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet, 2011. 43(12)252–5.View Article
  15. Li, J., X. Zhu, X. Wang, et al., Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet, 2012. 49(2): p. 76–8.View Article
  16. Wang, J.L., L. Cao, X.H. Li, et al., Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain, 2011. 134(Pt 12): p. 3493–3501.PubMedView Article
  17. Gardiner, A.R., K.P. Bhatia, M. Stamelou, et al., PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology, 2012. 79(21): p. 2115–21.PubMedView Article
  18. Ono, S., K.I. Yoshiura, A. Kinoshita, et al., Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet, 2012.
  19. Groffen, A.J., T. Klapwijk, A.F. van Rootselaar, et al., Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol, 2013. 260(1): p. 93–9.PubMedView Article
  20. Meneret, A., D. Grabli, C. Depienne, et al., PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology, 2012. 79(2): p. 170–4.PubMedView Article
  21. van Vliet, R., G. Breedveld, J. de Rijk-van Andel, et al., PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions. Neurology, 2012. 79(8): p. 777–84.PubMedView Article
  22. Liu, Q., Z. Qi, X.H. Wan, et al., Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. J Med Genet, 2012. 49(2): p. 79–82.PubMedView Article
  23. Specchio, N., A. Terracciano, M. Trivisano, et al., PRRT2 is mutated in familial and non-familial benign infantile seizures. Eur J Paediatr Neurol, 2013. 17(1): p. 77–81.PubMedView Article
  24. Cloarec, R., N. Bruneau, G. Rudolf, et al., PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology, 2012. 79(21): p. 2097–103.PubMedView Article
  25. Heron, S.E., B.E. Grinton, S. Kivity, et al., PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet, 2012. 90(1): p. 152–60.PubMedView Article
  26. Lee, H.Y., Y. Huang, N. Bruneau, et al., Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.Cell Rep}, 2012}. 1(1)}: p. 2–12View Article
  27. Lee, Y.C., M.J. Lee, H.Y. Yu, et al., PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort. PLoS One, 2012. 7(8): p. e38543.PubMedView Article
  28. Ishii, A., S. Yasumoto, Y. Ihara, et al., Genetic analysis of PRRT2 for benign infantile epilepsy, infantile convulsions with choreoathetosis syndrome, and benign convulsions with mild gastroenteritis. Brain Dev, 2012. doi: 10.1016/j.braindev.2012.09.006.
  29. Marini, C., V. Conti, D. Mei, et al., PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology, 2012. 79(21): p. 2109–14.PubMedView Article
  30. Scheffer, I.E., B.E. Grinton, S.E. Heron, et al., PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology}, 2012}. 79(21)}: p. 2104–9View Article
  31. de Vries, B., P.M. Callenbach, J.T. Kamphorst, et al., PRRT2 mutation causes benign familial infantile convulsions. Neurology, 2012. 79(21): p. 2154–5.PubMedView Article
  32. Schubert, J., R. Paravidino, F. Becker, et al., PRRT2 Mutations are the major cause of benign familial infantile seizures. Hum Mutat, 2012. 33(10): p. 1439–43.PubMedView Article
  33. Steinlein, O.K., M. Villain and C. Korenke, The PRRT2 mutation c.649dupC is the so far most frequent cause of benign familial infantile convulsionssorders: further PKD and ICCA cases and review of the literature. J Neurol, 2013. DOI 10.1007/s00415-012-6777-y.
  34. Becker, F., J. Schubert, P. Striano, et al., PRRT2-related disorders: further PKD and ICCA cases and review of the literature. J Neurol, 2013. DOI 10.1007/s00415-012-6777-y.
  35. Dale, R.C., A. Gardiner, J. Antony, et al., Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol, 2012. 54(10): p. 958–60.PubMedView Article
  36. Riant, F., E. Roze, C. Barbance, et al., PRRT2 mutations cause hemiplegic migraine. Neurology, 2012. 79(21): p. 2122–4.PubMedView Article
  37. Labate, A., P. Tarantino, G. Palamara, et al., Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP. Epilepsy Res, 2013. doi: 10.1016/j.eplepsyres.2012.10.014.
  38. Heron, S.E. and L.M. Dibbens, Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy. J Med Genet, 2013. 50(3): p. 133–9.
  39. Bhatia, K.P., The paroxysmal dyskinesias. J Neurol, 1999. 246(3)49–55.View Article
  40. Bruno, M.K., M. Hallett, K. Gwinn-Hardy, et al., Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology, 2004. 63(12): p. 2280–7.PubMedView Article
  41. Mehta, S.H., J.C. Morgan and K.D. Sethi, Paroxysmal dyskinesiaseurol,2009)11(3): p. 170–8.
  42. Strzelczyk, A., K. Burk and W.H. Oertel, Treatment of paroxysmal dyskinesias. Expert Opin Pharmacother, 2011. 12(1): p. 63–72.PubMedView Article
  43. Rainier, S., D. Thomas, D. Tokarz, et al., Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol, 2004. 61(7): p. 1025–9.
  44. Lee, H.Y., Y. Xu, Y. Huang, et al., The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet, 2004. 13(24): p. 3161–70.PubMedView Article
  45. Djarmati, A., M. Svetel, D. Momcilovic, et al., Significance of recurrent mutations in the myofibrillogenesis regulator 1 gene. Arch Neurol, 2005. 62(10): p. 1641.PubMedView Article
  46. Stefanova, E., A. Djarmati, D. Momcilovic, et al., Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation. Mov Disord, 2006. 21(11): p. 2010–5.PubMedView Article
  47. Spacey, S.D., P.J. Adams, P.C. Lam, et al., Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology, 2006. 66(10): p. 1588–90.PubMedView Article
  48. Dressler, D. and R. Benecke, Diagnosis and management of acute movement disorders. J Neurol, 2005. 252(11): p. 1299–306.PubMedView Article
  49. Bruno, M.K., H.Y. Lee, G.W. Auburger, et al., Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology, 2007. 68(21): p. 1782–9.PubMedView Article
  50. Hinson, V.K. and W.B. Haren, Psychogenic movement disorders. Lancet Neurol, 2006. 5(8): p. 695–700PubMedView Article
  51. Kamm, C., P. Mayer, M. Sharma, et al., New family with paroxysmal exercise-induced dystonia and epilepsy. Mov Disord, 2007. 22(6): p. 873–7.PubMedView Article
  52. Munchau, A., E.M. Valente, G.A. Shahidi, et al., A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. J Neurol Neurosurg Psychiatry, 2000. 68(5): p. 609–14.PubMedView Article
  53. Suls, A., P. Dedeken, K. Goffin, et al., Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain, 20081(Pt 7).
  54. Weber, Y.G., A. Storch, T.V. Wuttke, et al., GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest, 2008. 118(6): p. 2157–68.PubMed
  55. Schneider, S.A., C. Paisan-Ruiz, I. Garcia-Gorostiaga, et al., GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord, 2009. 24(11): p. 1684–8.PubMedView Article
  56. De Vivo, D.C., R.R. Trifiletti, R.I. Jacobson, et al., Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med, 1991. 325(10): p. 703–9.PubMedView Article
  57. Pons, R., A. Collins, M. Rotstein, et al., The spectrum of movement disorders in Glut-1 deficiency. Mov Disord, 2010.
  58. Suls, A., S.A. Mullen, Y.G. Weber, et al., Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol, 2009. 66(3): p. 415–9.PubMedView Article
  59. Arsov, T., S.A. Mullen, J.A. Damiano, et al., Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia, 2012. 53(12): p. e204–7.PubMedView Article
  60. Mullen, S.A., C. Marini, A. Suls, et al., Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol, 2011. 68(9): p. 1152–5.PubMedView Article
  61. Arsov, T., S.A. Mullen, S. Rogers, et al., Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol, 2012. 72(5): p. 807–15.PubMedView Article
  62. Striano, P., Y.G. Weber, M.R. Toliat, et al., GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology, 2012. 78(8): p. 557–62.PubMedView Article
  63. Klein, C. and P. Vieregge, [Non-epileptic paroxysmal movement disorders]. Nervenarzt, 1998. 69(8): p. 647–59.PubMedView Article
  64. Mullen, S.A., A. Suls, P. De Jonghe, et al., Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology, 2010. 75(5): p. 432–40.PubMedView Article
  65. Caraballo, R.H. and E. Vining, Ketogenic diet. Handb Clin Neurol, 2012. 108: p. 783–93.PubMedView Article
  66. Ito, S., H. Oguni, Y. Ito, et al., Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev, 2008. 30(3): p. 226–8.PubMedView Article
  67. Blakeley, J. and J. Jankovic, Secondary paroxysmal dyskinesias. Mov Disord, 2002. 17(4): p. 726–34.PubMedView Article
  68. Zenzola, A., M. De Mari, R. De Blasi, et al., Paroxysmal dystonia with thalamic lesion in multiple sclerosis. Neurol Sci, 200122(5): p. 391–4.PubMedView Article
  69. Camac, A., P. Greene and A. Khandji, Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Mov Disord, 1990. 5(3): p. 235–8.PubMedView Article
  70. Bhatia, K.P., Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol, 2001. 21(1): p. 69–74.PubMedView Article
  71. Kinsbourne, M., Hiatus Hernia with Contortions of the Neck. Lancet, 1964. 13: p. 1058–61.View Article
  72. Shahnawaz, M., L.R. van der Westhuizen and R.F. Gledhill, Episodic cervical dystonia associated with gastro-oesophageal reflux. A case of adult-onset Sandifer syndrome. Clin Neurol Neurosurg, 2001. 103(4): p. 212–5.PubMedView Article
  73. Somjit, S., Y. Lee, S.F. Berkovic, et al., Sandifer syndrome misdiagnosed as refractory partial seizures in an adult. Epileptic Disord, 2004. 6(1): p. 49–50.PubMed
  74. Nowak, M., A. Strzelczyk, W.H. Oertel, et al., A female adult with Sandifer’s syndrome and hiatal hernia misdiagnosed as epilepsy with focal seizures. Epilepsy Behav, 2012. 24(1): p. 141–2.PubMedView Article
  75. Jen, J.C., Hereditary episodic ataxias. Ann N Y Acad Sci, 2008. 1142: p. 250–3.PubMedView Article
  76. Hanna, M.G., Genetic neurological channelopathies. Nat Clin Pract Neurol, 2006. 2(5): p. 252–63.PubMedView Article
  77. Jen, J.C., T.D. Graves, E.J. Hess, et al., Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain, 2007. 130(Pt 10): p. 2484–93.PubMedView Article
  78. Browne, D.L., S.T. Gancher, J.G. Nutt, et al., Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet, 1994. 8(2): p. 136–40.PubMedView Article
  79. Chen, H., C. von Hehn, L.K. Kaczmarek, et al., Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics, 2007. 8(2): p. 131–5.PubMedView Article
  80. Comu, S., M. Giuliani and V. Narayanan, Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1. Ann Neurol, 1996. 40(4): p. 684–7.PubMedView Article
  81. Kinali, M., H. Jungbluth, L.H. Eunson, et al., Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscul Disord, 2004. 14(10): p. 689–93.PubMedView Article
  82. Klein, A., E. Boltshauser, J. Jen, et al., Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy}. Neuropediatrics, 2004. 35(2): p. 147–9.PubMedView Article
  83. Zuberi, S.M., L.H. Eunson, A. Spauschus, et al., A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999. 122 (Pt 5): p. 817–25.PubMedView Article
  84. Strupp, M., A. Zwergal and T. Brandt, Episodic ataxia type 2. Neurotherapeutics, 2007. 4(2): p. 267–73.PubMedView Article
  85. Jen, J., G.W. Kim and R.W. Baloh, Clinical spectrum of episodic ataxia type 2. Neurology, 2004. 62(1): p. 17–22.PubMedView Article
  86. Kullmann, D.M. and M.G. Hanna, Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol, 2002. 1(3): p. 157–66.PubMedView Article
  87. Vahedi, K., A. Joutel, P. Van Bogaert, et al., A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol, 1995. 37(3): p. 289–93.PubMedView Article
  88. von Brederlow, B., A.F. Hahn, W.J. Koopman, et al., Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet, 1995. 4(2): p. 279–84View Article
Metadaten
Titel
Im Grenzgebiet zwischen Bewegungsstörungen und Epilepsien
Paroxysmale Dyskinesien
verfasst von
Dr. med. Adam Strzelczyk
Philipp S. Reif
Katrin Bürk
Wolfgang H. Oertel
Karl Martin Klein
Publikationsdatum
11.06.2013
Verlag
Urban and Vogel
Erschienen in
DNP – Die Neurologie & Psychiatrie / Ausgabe 6/2013
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI
https://doi.org/10.1007/s15202-013-0287-3

Weitere Artikel der Ausgabe 6/2013

DNP - Der Neurologe & Psychiater 6/2013 Zur Ausgabe

Pharmaforum

TOWER-Studie bestätigt Wirksamkeit von Teriflunomid

Praxis konkret

Licht für Demenzkranke

Kurz gemeldet

Portfolio erweitert

Praxis konkret

GOÄ-Nr. 34 — eine unterschätzte Gebührenordnungsposition

Kurz gemeldet

Progression deutlich verlangsamt

Medizin aktuell

Reduktion der Trinkmenge als Strategie

Neu in den Fachgebieten Neurologie und Psychiatrie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe